HSBC/CALL/PFIZER INC/60/0.1/14.01.26 Share Price

Warrant

DE000HG810V4

Market Closed - Börse Stuttgart 07:24:13 29/05/2024 BST
0.008 EUR -20.00% Intraday chart for HSBC/CALL/PFIZER INC/60/0.1/14.01.26
Current month+166.67%
1 month+166.67%
Date Price Change
29/05/24 0.008 -20.00%
28/05/24 0.01 -9.09%
27/05/24 0.011 +175.00%
24/05/24 0.004 -42.86%
23/05/24 0.007 +600.00%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 07:24 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer HSBC
WKN HG810V
ISINDE000HG810V4
Date issued 02/02/2023
Strike 60 $
Maturity 14/01/2026 (595 Days)
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.001
Spread 0.01
Spread %47.62%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.82 USD
Average target price
31.92 USD
Spread / Average Target
+14.72%
Consensus